A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Lessons from past emergencies help in the response to recent hurricanes

by Doug Beaudoin, Principal, Deloitte Consulting LLP

In the wake of Hurricane Harvey, which set a record for the most rainfall from a single storm in the continental US, and Hurricane Irma, which has set new flood records in northeast Florida, many journalists and commentators have looked back to the emergency response to Hurricane Katrina for comparison. It’s interesting to reflect on the progress we have made in emergency response and health care connectivity over the past 12 years.

Read more

To ensure low-cost generic drugs, manufacturers must find equilibrium

by Faith Glazier, Principal, Deloitte Consulting LLP

Headlines and politics have been focusing quite a bit of attention on the price of pharmaceuticals – particularly generic drugs. While manufacturers of generic drugs have been effective at keeping treatment costs down, pressure to trim costs further could have the opposite effect, particularly if it leads to unprofitable products.

Generics account for the vast majority of drug sales in the US,

Read more

Back to school: The reading, writing, and ‘rithmetic of health care

by Sarah Thomas, Managing Director, Deloitte Center for Health Solutions, Deloitte Services LP

Well, it is that time of year again, when dry leaves start skittering around and the days get shorter. School supplies have been purchased and tucked into backpacks, and first-day-of-school photos have been filling up my Facebook page. Summer recess is also over for Congress, which returned to work after Labor Day. What can we expect from the Senate and the House during what remains of 2017?

Read more

Technology, value-based care are changing the journey for cardiac patients and device manufacturers

by Glenn Snyder, Principal, MedTech Practice Leader, Deloitte Consulting LLP

For those who suffer from cardiovascular disease (CVD), less-invasive treatments, advanced analytics, and wearable medical devices are helping to improve the patient journey. For medical technology (medtech) companies that manufacture CVD devices, the landscape is also shifting as they collaborate with non-traditional companies, acquire innovative solutions, and consolidate.

In our new report, Getting to the heart of the cardiovascular market,

Read more

Breakthroughs in nanotechnology may transform treatments

by Doug Beaudoin, Principal, Deloitte Consulting LLP

Researchers are moving closer to a breakthrough in nanotechnology that has the potential to regrow damaged organs and heal serious wounds. Nanochips housed in a tiny pad the size of a penny can reprogram skin cells and generate cells in a process called nanotransfection. In trials, the non-invasive procedure restored the function of badly damaged blood vessels in days by firing DNA into skin cells from a small electric current.

Read more

Outcomes measurement in the modern era: A hospital imperative

by Claire Cruse, Health Policy Manager, Deloitte Center for Health Solutions, Deloitte Services LP

The so-called “father of outcomes management” – Ernest Codman – began developing ways to standardize and track patient results in the early 1900s. Dr. Codman pioneered the outcomes movement, using what he called “End Results Cards” to document demographic, diagnosis, and treatment data on each patient he treated.

Today, his legacy lives on in many ways,

Read more